Table 1.
Demographic and Clinical Characteristics by Treatment Group at Baseline.
| Treatment Group |
|||
|---|---|---|---|
| SGB (n=17) M (SD) |
Sham-control (n=19) M (SD) |
p-value | |
| Demographics | |||
| Age (years) | 51.47 (2.60) | 53.26 (4.07) | 0.13 |
| Years of Education | 15.29 (1.66) | 14.43 (1.78) | 0.21 |
| Body Mass Index | 28.71 (5.01) | 28.68 (5.74) | 0.99 |
| Race, n (%) | 0.58 | ||
| White | 6 (35) | 10 (53) | |
| Black | 10 (59) | 8 (42) | |
| Hispanic | 1 (6) | 1 (5) | |
| Natural menopause, n (%) | 15 (88) | 12 (63) | 0.09 |
| Postmenopausal status, <5 years since LMP (%) | 11 (65) | 12 (63) | 0.92 |
| Menopausal Symptoms | |||
| CES-D | 11.88 (7.01) | 12.11 (9.06) | 0.94 |
| Pittsburgh Sleep Quality Index | |||
| Latency | 1.24 (1.03) | 1.68 (1.06) | 0.21 |
| Quality | 1.76 (0.76) | 1.84 (0.76) | 0.76 |
| Disturbances | 2.00 (0.50) | 1.84 (0.60) | 0.40 |
| Green Climacteric Scale | |||
| Psychological | 8.35 (4.14) | 8.74 (5.02) | 0.81 |
| Vasomotor | 4.06 (1.25) | 4.21 (1.18) | 0.71 |
| Somatic | 3.94 (3.51) | 4.11 (3.49) | 0.89 |
| Utian Quality of Life (UQOL) | 80.53 (8.32) | 82.27 (11.34) | 0.60 |
| Vasomotor Symptoms (Daily Count)‡ | |||
| Objective (via monitor) | |||
| Total | 15.13 (12.84) | 10.01 (10.22) | 0.26 |
| Awake | 12.47 (11.00) | 7.08 (7.23) | 0.15 |
| Asleep | 2.67 (2.16) | 2.92 (4.27) | 0.84 |
| Reported (via monitor) | |||
| Total | 16.93 (7.53) | 17.25 (9.32) | 0.92 |
| Awake | 13.33 (8.04) | 13.71 (6.72) | 0.90 |
| Asleep | 3.60 (2.29) | 3.54 (3.95) | 0.96 |
Note. LMP=last menstrual period. SGB= Stellate Ganglion Blockade. CES-D = Center for Epidemiological Studies - Depression Scale.
‡
Valid objective data was available on 28/36 women (15 SGB; 13 sham-control).